retatrutide liver effects Retatrutide: A Promising Breakthrough for Fatty Disease Xia & He Publishing

However, the majority of clinical evidence supports once-weekly administration as the optimal balance between efficacy and tolerability

People living longer with obesity may have associated comorbidity [16], involving musculoskeletal, cardiometabolic and mental health complications, with higher rates of malignancy [17], although it remains unclear the extent to which cumulative exposure to obesity impacts upon their respective clinical outcomes [18,19,20,21]

Goodman, A.L

Strengthening reimbursement pathways, including emerging Medicare coverage initiatives, are easing affordability constraints that previously limited adoption

10.1016/j.gerinurse.2023.02.012 224 NouchiR.TakiY.TakeuchiH.SekiguchiA.HashizumeH.NozawaT.et al (2014)